Pancreatic Cancer Research

ResearcherMayo Clinic in ArizonaActive in the last 2 years

Yu-Hui H. Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4485-9306; OpenAlex author ID A5057935184. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. First author DOI 10.1002/jso.70361↗
  2. Adjuvant Chemotherapy Is Not Associated With Improved Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma With Persistent Lymphovascular Invasio… First author DOI 10.1002/jso.70414↗
  3. Association of Textbook Outcome and Surgical Case Volume with Long-Term Survival in Patients Undergoing Surgical Resection for Pancreatic Cancer: In Reply to L… First author DOI 10.1097/xcs.0000000000000749↗
  4. Association of Textbook Outcome and Surgical Case Volume with Long-Term Survival in Patients Undergoing Surgical Resection for Pancreatic Cancer. Co-author DOI 10.1097/xcs.0000000000000407↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nabil Wasif · 4 shared papers, 2022–2026 · strength 1.18
  2. Chee‐Chee Stucky · 3 shared papers, 2022–2026 · strength 0.79
  3. Zhi Ven Fong · 2 shared papers, 2026 · strength 0.59
  4. Mitesh J. Borad · 1 shared paper, 2026 · strength 0.30
  5. Richard J. Bold · 1 shared paper, 2026 · strength 0.30
  6. Valerie L. Armstrong · 1 shared paper, 2026 · strength 0.30
  7. Tanios Bekaii‐Saab · 1 shared paper, 2026 · strength 0.30
  8. Rahul Pannala · 1 shared paper, 2026 · strength 0.29
  9. Patricia G Lu · 1 shared paper, 2026 · strength 0.29
  10. Roshini Kalagara · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.